A detailed history of High Net Worth Advisory Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 16,209 shares of MRK stock, worth $1.61 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
16,209
Previous 16,242 0.2%
Holding current value
$1.61 Million
Previous $2.01 Million 8.46%
% of portfolio
0.51%
Previous 0.6%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$111.15 - $128.97 $3,667 - $4,256
-33 Reduced 0.2%
16,209 $1.84 Million
Q2 2024

Jul 17, 2024

SELL
$123.8 - $132.96 $14,360 - $15,423
-116 Reduced 0.71%
16,242 $2.01 Million
Q1 2024

Apr 11, 2024

BUY
$113.24 - $131.95 $2,831 - $3,298
25 Added 0.15%
16,358 $2.16 Million
Q4 2023

Jan 08, 2024

SELL
$100.18 - $109.02 $10,418 - $11,338
-104 Reduced 0.63%
16,333 $1.78 Million
Q3 2023

Oct 05, 2023

BUY
$102.95 - $114.33 $7,309 - $8,117
71 Added 0.43%
16,437 $1.69 Million
Q2 2023

Jul 07, 2023

BUY
$108.61 - $118.38 $92,101 - $100,386
848 Added 5.46%
16,366 $1.89 Million
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $52,396 - $58,463
-509 Reduced 3.18%
15,518 $1.65 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $108,775 - $139,464
-1,244 Reduced 7.2%
16,027 $1.78 Million
Q3 2022

Oct 24, 2022

SELL
$84.53 - $94.96 $8,453 - $9,496
-100 Reduced 0.58%
17,271 $1.49 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $276,602 - $313,542
3,313 Added 23.57%
17,371 $1.58 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $46,825 - $52,488
637 Added 4.75%
14,058 $1.15 Million
Q4 2021

Apr 27, 2022

BUY
$72.28 - $90.54 $970,069 - $1.22 Million
13,421 New
13,421 $1.08 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.